Copyright
©The Author(s) 2022.
World J Psychiatry. Jun 19, 2022; 12(6): 814-826
Published online Jun 19, 2022. doi: 10.5498/wjp.v12.i6.814
Published online Jun 19, 2022. doi: 10.5498/wjp.v12.i6.814
Demographic & clinical variables | Patients with BD, n = 160 |
Age (yr) | |
mean ± SD (range) | 43.96 ± 13.51 (18-65) |
Sex | |
Male, n (%) | 107 (67) |
Female. n (%) | 53 (33) |
Marital status | |
Currently single, n (%) | 27 (17) |
Currently married, n (%) | 133 (83) |
Year of education | |
mean ± SD (range) | 11.85 ± 3.27 (5-18) |
Occupation | |
Not earning, n (%) | 43 (26) |
Earning, n (%) | 117 (74) |
Family income, in rupees per month | |
mean ± SD (range) | 36977 ± 29385 (1500-131500) |
Family type | |
Nuclear, n (%) | 106 (66) |
Non-nuclear, n (%) | 54 (34) |
Residence | |
Rural, n (%) | 128 (80) |
Urban, n (%) | 32 (20) |
Middle socioeconomic class, n (%) | 110 (69) |
Diagnosis | |
BD type I, n (%) | 157 (98) |
BD type II, n (%) | 3 (02) |
Most recent episode | |
Manic or hypomanic1, n (%) | 88 (55) |
Depressive, n (%) | 72 (45) |
Age of onset (yr) | |
mean ± SD (range) | 26.11 ± 09.50 (12-60) |
Duration of illness (mo) | |
mean ± SD (range) | 210.88 ± 132.73 (12-600) |
Duration of treatment (mo) | |
mean ± SD (range) | 202.05 ± 129.01 (12-570) |
Duration of current remission (mo) | |
mean ± SD (range) | 19.82 ± 38.99 (4-456) |
HDRS score | |
mean ± SD (range) | 2.24 ± 1.18 (1-7) |
YMRS score | |
mean ± SD (range) | 1.56 ± 0.830 (1-6) |
Insight-YMRS item 11 score | |
mean ± SD (range) | 0.50 ± 0.56 (0-2) |
Insight-HDRS item 17 score | |
mean ± SD (range) | 0.55 ± 0.4 (0-2) |
GAF score | |
mean ± SD (range) | 69.04 ± 11.245 (48-92) |
Total number of episodes | |
mean ± SD (range) | 6.94 ± 5.77 (1-40) |
Number of manic episodes1 | |
mean ± SD (range) | 3.68 ± 3.62 (0-30) |
Number of depressive episodes | |
mean ± SD (range) | 2.73 ± 2.71 (0-12) |
Most recent episode polarity | |
Manic or hypomanic1, n (%) | 88 (55) |
Depressive, n (%) | 72 (45) |
Average severity of manic episodes1,2, n (%) | 1.77 ± 0.62 (1-3) median 2 |
Average severity of depressive episodes2, n (%) | 1.49 ± 0.56 (0-3) median 1 |
Patients with at least one episode of psychotic mania, n (%) | 107 (67) |
Patients with at least one episode of psychotic depression, n (%) | 84 (53) |
Rapid cycling affective disorder, n (%) | 30 (19) |
Seasonal pattern, n (%) | 62 (39) |
Lifetime suicidal attempts, n (%) | 34 (21) |
Patients with any lifetime psychiatric comorbidity, n (%) | 43 (27) |
Patients with comorbid substance use disorders, n (%) | 34 (21) |
Patients with comorbid anxiety disorders, n (%) | 18 (12) |
Patients with lifetime comorbid physical illness, n (%) | 54 (34) |
Lifetime history of inadequate medication-adherence, n (%) | 77 (48) |
Lifetime history of relapses or breakthrough episodes, n (%) | 85 (53) |
Any history of hospitalization, n (%) | 82 (51) |
On mood stabilizer prophylaxis, n (%) | 160 (100) |
On lithium carbonate, n (%) | 116 (73) |
Average dose | 720 ± 193 mg/d |
On sodium valproate, n (%) | 42 (27) |
Average dose | 1021 ± 284 mg/d |
On antipsychotics, n (%) | 105 (66) |
On antidepressants, n (%) | 40 (25) |
- Citation: Kumar R, Chakrabarti S, Ghosh A. Composition of treatment alliance in bipolar disorder: A cross-sectional study of patients’ perspectives. World J Psychiatry 2022; 12(6): 814-826
- URL: https://www.wjgnet.com/2220-3206/full/v12/i6/814.htm
- DOI: https://dx.doi.org/10.5498/wjp.v12.i6.814